TNFAIP3 and diffuse large B-cell lymphoma: Notably, exosomes carrying miR-125b-5p can reduce DLBCL sensitivity to rituximab by inhibiting the expression of tumor necrosis factor necrosis factor-α induced protein 3 (TNFAIP3), also known as A20 [288].